# SS Innovations International: company

Canonical ID: `d379bc4f-a144-46c8-8c2a-17554ab559e1`

## Key facts

- **Ticker:** Nasdaq: SSII
- **Systems installed:** 138 across 8 countries
- **Procedures performed:** 7,300+
- **FDA status:** 510(k) submitted late 2025
- **CEO:** Dr. Sudhir Srivastava
- **Stock:** Nasdaq: SSII
- **Product:** SSi Mantra 3 surgical robotic system
- **Funding raised:** 8.6M (2025)

- **Slug:** ss-innovations
- **HQ:** United States

## Models

- [SSi Mantra](/models/ssi-mantra.md) (surgical) (id: `2cd2961a-8f57-487b-a5e4-faae826ff59f`)

## Current leadership (1)

- [Sudhir Srivastava](/people/sudhir-srivastava.md) Founder, Chairman & CEO (_reported, not verified_)

## Founders (1)

- [Sudhir Srivastava](/people/sudhir-srivastava.md) (cofounder)

## Supplies to

_No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this company's outbound edges._

_Outbound supply edges. Each appears when verified with at least two strong sources. Sources are append-only; corrections add new sources rather than rewrite history._

## Sources (2)

1. https://www.massdevice.com/ss-innovations-submits-mantra-robot-fda/
2. https://www.biopharmaboardroom.com/news/6/4101/ss-innovations-submits-510k-application-to-fda-for-ssi-mantra-surgical-robotic-system.html

_API: GET /v1/companies/d379bc4f-a144-46c8-8c2a-17554ab559e1 · canonical URL: /companies/ss-innovations_